Please enable JavaScript to continue using this application.

Compare $ABUS vs $EPRX.TO | Chartloom

Compare

$ABUS vs $EPRX.TO

ABUS

Arbutus Biopharma Corp

EPRX.TO

Error

Compare $ABUS vs $EPRX.TO

ABUSArbutus Biopharma Corp

EPRX.TO

Error

ABUSArbutus Biopharma Corp

Market cap

$834M

P/E (TTM)

5.44x

Forward P/E (NTM)

—

Forward P/S (NTM)

204.32x

Rev growth (TTM)

1078.8%

YTD performance

-11.5%

52W performance

1.0%

FCF yield

-3.0%

EPRX.TO

Market cap

—

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

—

52W performance

—

FCF yield

—

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

ABUS

EPRX.TO

Not enough overlapping price history for this window.

Detailed metrics comparison

ABUS

Arbutus Biopharma Corp

EPRX.TO

Market Cap

ABUS$834M

EPRX.TO

Enterprise Value

ABUS$818M

EPRX.TO

Price

ABUS$4.22

EPRX.TO

P/E Ratio

ABUS5.44x

EPRX.TO

P/S Ratio

ABUS4.59x

EPRX.TO

EV/Sales

ABUS4.50x

EPRX.TO

EV/EBITDA

ABUS4.98x

EPRX.TO

P/B Ratio

ABUS3.41x

EPRX.TO

P/FCF Ratio

ABUSN/A

EPRX.TO

EV/FCF

ABUS-33.20x

EPRX.TO

PEG Ratio

ABUSN/A

EPRX.TO

Forward P/E (NTM)

ABUSN/A

EPRX.TO

Forward P/S (NTM)

ABUS204.32x

EPRX.TO

Revenue (TTM)

ABUS$182M

EPRX.TO

Revenue Growth (YoY)

ABUS1078.8%

EPRX.TO

Forward Rev Growth

ABUS-97.7%

EPRX.TO

Gross Margin (TTM)

ABUS0.0%

EPRX.TO

Operating Margin (TTM)

ABUS82.0%

EPRX.TO

EBITDA Margin (TTM)

ABUS82.2%

EPRX.TO

Net Margin (TTM)

ABUS84.2%

EPRX.TO

FCF Margin (TTM)

ABUS-13.6%

EPRX.TO

Net Income (TTM)

ABUS$153M

EPRX.TO

FCF (TTM)

ABUS$-25M

EPRX.TO

EPS (TTM)

ABUS$0.78

EPRX.TO

ROE (TTM)

ABUS91.0%

EPRX.TO

ROA (TTM)

ABUS82.3%

EPRX.TO

ROIC (TTM)

ABUS89.2%

EPRX.TO

Cash

ABUS$19M

EPRX.TO

Debt

ABUS$3M

EPRX.TO

Net Cash/Debt

ABUS$16M

EPRX.TO

Current Ratio (TTM)

ABUS81.42x

EPRX.TO

Quick Ratio (TTM)

ABUS80.97x

EPRX.TO

Debt/Equity (TTM)

ABUS0.01x

EPRX.TO

Debt/Assets (TTM)

ABUS0.0%

EPRX.TO

Interest Coverage (TTM)

ABUSN/A

EPRX.TO

Net Debt/EBITDA (TTM)

ABUS0.00x

EPRX.TO

Beta

ABUS0.79

EPRX.TO

52W Performance

ABUS1.0%

EPRX.TO

YTD Performance

ABUS-11.5%

EPRX.TO

% from 52W High

ABUS-22.6%

EPRX.TO

% from 52W Low

ABUS20.6%

EPRX.TO

Asset Turnover (TTM)

ABUS0.98x

EPRX.TO

FCF Yield (TTM)

ABUS-3.0%

EPRX.TO

Earnings Yield (TTM)

ABUS18.4%

EPRX.TO

Dividend Yield (TTM)

ABUSN/A

EPRX.TO

Rule of 40

ABUS1,065.2

EPRX.TO

EV/GP/RG

ABUSN/A

EPRX.TO

Ticker research

View ABUS research View EPRX.TO research

Metric	ABUS Arbutus Biopharma Corp	EPRX.TO
Market & Valuation
Market Cap	$834M
Enterprise Value	$818M
Price	$4.22
P/E Ratio	5.44x
P/S Ratio	4.59x
EV/Sales	4.50x
EV/EBITDA	4.98x
P/B Ratio	3.41x
P/FCF Ratio	N/A
EV/FCF	-33.20x
PEG Ratio	N/A
Forward P/E (NTM)	N/A
Forward P/S (NTM)	204.32x
Revenue & Growth
Revenue (TTM)	$182M
Revenue Growth (YoY)	1078.8%
Forward Rev Growth	-97.7%
Profitability
Gross Margin (TTM)	0.0%
Operating Margin (TTM)	82.0%
EBITDA Margin (TTM)	82.2%
Net Margin (TTM)	84.2%
FCF Margin (TTM)	-13.6%
Net Income (TTM)	$153M
FCF (TTM)	$-25M
EPS (TTM)	$0.78
ROE (TTM)	91.0%
ROA (TTM)	82.3%
ROIC (TTM)	89.2%
Financial Health
Cash	$19M
Debt	$3M
Net Cash/Debt	$16M
Current Ratio (TTM)	81.42x
Quick Ratio (TTM)	80.97x
Debt/Equity (TTM)	0.01x
Debt/Assets (TTM)	0.0%
Interest Coverage (TTM)	N/A
Net Debt/EBITDA (TTM)	0.00x
Performance
Beta	0.79
52W Performance	1.0%
YTD Performance	-11.5%
% from 52W High	-22.6%
% from 52W Low	20.6%
Efficiency & Yields
Asset Turnover (TTM)	0.98x
FCF Yield (TTM)	-3.0%
Earnings Yield (TTM)	18.4%
Dividend Yield (TTM)	N/A
Other
Rule of 40	1,065.2
EV/GP/RG	N/A
Ticker research	View ABUS research	View EPRX.TO research

Valuation

Growth & revenue

Profitability & performance

Detailed metrics comparison

ABUS

Arbutus Biopharma Corp

EPRX.TO

Market Cap

ABUS$834M

EPRX.TO

Enterprise Value

ABUS$818M

EPRX.TO

Price

ABUS$4.22

EPRX.TO

P/E Ratio

ABUS5.44x

EPRX.TO

P/S Ratio

ABUS4.59x

EPRX.TO

EV/Sales

ABUS4.50x

EPRX.TO

EV/EBITDA

ABUS4.98x

EPRX.TO

P/B Ratio

ABUS3.41x

EPRX.TO

P/FCF Ratio

ABUSN/A

EPRX.TO

EV/FCF

ABUS-33.20x

EPRX.TO

PEG Ratio

ABUSN/A

EPRX.TO

Forward P/E (NTM)

ABUSN/A

EPRX.TO

Forward P/S (NTM)

ABUS204.32x

EPRX.TO

Revenue (TTM)

ABUS$182M

EPRX.TO

Revenue Growth (YoY)

ABUS1078.8%

EPRX.TO

Forward Rev Growth

ABUS-97.7%

EPRX.TO

Gross Margin (TTM)

ABUS0.0%

EPRX.TO

Operating Margin (TTM)

ABUS82.0%

EPRX.TO

EBITDA Margin (TTM)

ABUS82.2%

EPRX.TO

Net Margin (TTM)

ABUS84.2%

EPRX.TO

FCF Margin (TTM)

ABUS-13.6%

EPRX.TO

Net Income (TTM)

ABUS$153M

EPRX.TO

FCF (TTM)

ABUS$-25M

EPRX.TO

EPS (TTM)

ABUS$0.78

EPRX.TO

ROE (TTM)

ABUS91.0%

EPRX.TO

ROA (TTM)

ABUS82.3%

EPRX.TO

ROIC (TTM)

ABUS89.2%

EPRX.TO

Cash

ABUS$19M

EPRX.TO

Debt

ABUS$3M

EPRX.TO

Net Cash/Debt

ABUS$16M

EPRX.TO

Current Ratio (TTM)

ABUS81.42x

EPRX.TO

Quick Ratio (TTM)

ABUS80.97x

EPRX.TO

Debt/Equity (TTM)

ABUS0.01x

EPRX.TO

Debt/Assets (TTM)

ABUS0.0%

EPRX.TO

Interest Coverage (TTM)

ABUSN/A

EPRX.TO

Net Debt/EBITDA (TTM)

ABUS0.00x

EPRX.TO

Beta

ABUS0.79

EPRX.TO

52W Performance

ABUS1.0%

EPRX.TO

YTD Performance

ABUS-11.5%

EPRX.TO

% from 52W High

ABUS-22.6%

EPRX.TO

% from 52W Low

ABUS20.6%

EPRX.TO

Asset Turnover (TTM)

ABUS0.98x

EPRX.TO

FCF Yield (TTM)

ABUS-3.0%

EPRX.TO

Earnings Yield (TTM)

ABUS18.4%

EPRX.TO

Dividend Yield (TTM)

ABUSN/A

EPRX.TO

Rule of 40

ABUS1,065.2

EPRX.TO

EV/GP/RG

ABUSN/A

EPRX.TO

Ticker research

View ABUS research View EPRX.TO research

Metric	ABUS Arbutus Biopharma Corp	EPRX.TO
Market & Valuation
Market Cap	$834M
Enterprise Value	$818M
Price	$4.22
P/E Ratio	5.44x
P/S Ratio	4.59x
EV/Sales	4.50x
EV/EBITDA	4.98x
P/B Ratio	3.41x
P/FCF Ratio	N/A
EV/FCF	-33.20x
PEG Ratio	N/A
Forward P/E (NTM)	N/A
Forward P/S (NTM)	204.32x
Revenue & Growth
Revenue (TTM)	$182M
Revenue Growth (YoY)	1078.8%
Forward Rev Growth	-97.7%
Profitability
Gross Margin (TTM)	0.0%
Operating Margin (TTM)	82.0%
EBITDA Margin (TTM)	82.2%
Net Margin (TTM)	84.2%
FCF Margin (TTM)	-13.6%
Net Income (TTM)	$153M
FCF (TTM)	$-25M
EPS (TTM)	$0.78
ROE (TTM)	91.0%
ROA (TTM)	82.3%
ROIC (TTM)	89.2%
Financial Health
Cash	$19M
Debt	$3M
Net Cash/Debt	$16M
Current Ratio (TTM)	81.42x
Quick Ratio (TTM)	80.97x
Debt/Equity (TTM)	0.01x
Debt/Assets (TTM)	0.0%
Interest Coverage (TTM)	N/A
Net Debt/EBITDA (TTM)	0.00x
Performance
Beta	0.79
52W Performance	1.0%
YTD Performance	-11.5%
% from 52W High	-22.6%
% from 52W Low	20.6%
Efficiency & Yields
Asset Turnover (TTM)	0.98x
FCF Yield (TTM)	-3.0%
Earnings Yield (TTM)	18.4%
Dividend Yield (TTM)	N/A
Other
Rule of 40	1,065.2
EV/GP/RG	N/A
Ticker research	View ABUS research	View EPRX.TO research